DuPont to acquire Ultrafiltration Membrane biz from BASF

dupont-to-acquire-ultrafiltration-membrane-biz-from-basf

Extending world-class water purification capabilities to meet growing customer demand

DuPont Safety & Construction (DuPont) has signed an agreement to acquire the Ultrafiltration Membrane business from BASF including inge GmbH. The transaction, including the business’ international workforce, its headquarters and production site in Greifenberg, Germany, and associated intellectual property currently owned by BASF SE., is expected to close by the end of 2019 subject to customary closing conditions and regulatory approvals. Financial terms of the agreement were not disclosed.

“As a global leader in innovative water solutions, we are continually looking for ways to help our customers solve water challenges around the world,” said Rose Lee, President, DuPont Safety & Construction. “This technology in combination with inge’s expert team further broadens our portfolio and enhances our ability to design tailored, integrated solutions for drinking water, industrial and waste water treatment applications globally.”

The combination of the DuPont and BASF ultrafiltration technologies adds to DuPont’s leading portfolio of water purification and separation technologies including ultrafiltration, reverse osmosis and ion exchange resins.

“Water is local, but science is global,” said HP Nanda, Global Vice President and General Manager, DuPont Water Solutions.  “We need a broad portfolio of technologies to solve our customers’ challenges. The industry-leading, multi-bore PES Ultra Filtration technology from BASF complements our own high-flow PVDF technology providing more choice for our customers.”

“The inge team has done a great job developing the Ultrafiltration Membrane technology into a well-established player in the market. However, synergies with BASF are very limited,” said Anup Kothari, President, Performance Chemicals, BASF. “For the Ultrafiltration Membrane business, becoming part of DuPont, a strategic buyer, provides strong value creation potential and will enable it to reach the next level of growth.”

Read Previous

Cargill invests $5M for sugar reduced chocolate

Read Next

Fonterra sells 50% stake in DFE Pharma for $633M NZD

Leave a Reply